Acetaminophen

Acetaminophen

SCHEMBL2128715

CC(=O)Nc1ccc(O)cc1.c1cc(-c2ccncc2)ccn1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FAAHPTGS1PTGS2TRPV1

The experimentally established mechanism targets of Acetaminophen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.71
▸ ALDH1A1 P00352 4/20 0.71
▸ TSHR P16473 2/20 0.71
▸ MEN1 O00255 2/20 0.71
▸ KMT2A Q03164 2/20 0.71
▸ CA12 O43570 1/20 0.71
▸ BRD4 O60885 1/20 0.71
▸ NR1I2 O75469 1/20 0.71
▸ CA1 P00915 1/20 0.71
▸ CA2 P00918 1/20 0.71
▸ MB P02144 1/20 0.71
▸ CYP1A1 P04798 1/20 0.71
▸ CA3 P07451 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ RARG P13631 1/20 0.71
▸ ALOX5AP P20292 1/20 0.71
▸ CA4 P22748 1/20 0.71
▸ CA7 P43166 1/20 0.71
▸ NR1I3 Q14994 1/20 0.71
▸ CA9 Q16790 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaminophen SCHEMBL1649625 0.98 MAPT (0.69) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL3728246 0.91 SMN1; SMN2 (0.76) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL2605857 0.87 KMT2A (0.87) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL27702503 0.85 KMT2A (0.91) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL252939 0.84 KMT2A (1.00) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL3480 0.84 KMT2A (1.00) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL8937727 0.84 KMT2A (1.00) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL5081499 0.82 KMT2A (0.95) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL20541508 0.82 ALDH1A1 (0.95) MAPTALDH1A1TSHRMEN1KMT2A
Acetaminophen SCHEMBL10325382 0.82 KMT2A (0.95) MAPTALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608339-B8 PHARMACEUTICAL CO-CRYSTAL OF CELECOXIB-NICOTINAMIDE MCNEIL PPC INC (US) 2012-04-25 — — EP claimed
EP-1608339-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN Transform Pharmaceuticals, Inc. (US) 2005-12-28 — — EP claimed
WO-2004078161-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPTINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN TRANSFORM PHARMACEUTICALS, INC. (US) 2004-09-16 — — WO claimed
EP-1631260-A2 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN Transform Pharmaceuticals, Inc. (US) 2006-03-08 — — EP disclosed
WO-2004078163-A2 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN TRANSFORM PHARMACEUTICALS, INC. (US) 2004-09-16 — — WO disclosed
Send feedback